Your browser doesn't support javascript.
loading
Update: Mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab use.
Albers, Frank C; Hozawa, Soichiro; Bratton, Daniel J; Yancey, Steven W; Prazma, Charlene M; Humbert, Marc; Liu, Mark C.
Afiliação
  • Albers FC; Respiratory Medical Franchise, GSK, Research Triangle Park, NC, USA.
  • Hozawa S; Hiroshima Allergy and Respiratory Clinic, Hiroshima, Japan.
  • Bratton DJ; Clinical Statistics, GSK, Uxbridge, UK.
  • Yancey SW; Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USA.
  • Prazma CM; Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USA.
  • Humbert M; Assistance Publique-Hôpitaux de Paris, Département Hospitalo-Universitaire Thorax Innovation, Service de Pneumologie, Hôpital Bicêtre, Université Paris-Sud, INSERM Unités Mixte de Recherche 999, Le Kremlin-Bicêtre, France.
  • Liu MC; Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USA.
Allergy ; 75(4): 942-946, 2020 04.
Article em En | MEDLINE | ID: mdl-31520471
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Eosinofilia Pulmonar / Asma / Antiasmáticos Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Eosinofilia Pulmonar / Asma / Antiasmáticos Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article